Breast Biopsy Market Report 2026
Breast Biopsy Market Report 2026
Global Outlook – By Type (Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits, Liquid Biopsy Instruments, Other Types), By Image Guided Technology (Magnetic Resonance Imaging (MRI) Guided Breast Biopsy, Ultrasound Guided Breast Biopsy, Mammography Guided Stereotactic Biopsy, Computed Tomography (CT) Guided Biopsy, Other Image Guided Technologies), By Procedure (Needle Breast Biopsy, Open Surgical Breast Biopsy, Liquid Breast Biopsy), By Application (Hospitals, Clinics, Diagnostic Centers, Other Applications) – Market Size, Trends, Strategies, and Forecast to 2035
Breast Biopsy Market Overview
• Breast Biopsy market size has reached to $1.53 billion in 2025 • Expected to grow to $2.17 billion in 2030 at a compound annual growth rate (CAGR) of 7.2% • Growth Driver: Rising Breast Cancer Cases Drive Increasing Demand For Breast Biopsy Procedures • Market Trend: Ultrasound-Visible Markers Enhance Biopsy Site Localization and Detection During Breast Procedures • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.
What Is Covered Under Breast Biopsy Market?
A breast biopsy is a medical procedure in which a small sample of breast tissue is removed and examined under a microscope to determine if it is cancerous or benign. It is typically performed when a lump or abnormality is detected in the breast through imaging tests or physical exams. The biopsy can be done using various methods, such as needle biopsy or surgical biopsy, often guided by imaging techniques such as ultrasound, and mammography. The main types of breast biopsy are biopsy needles, guidance systems, biopsy tables, localization wires, assay kits, liquid biopsy instruments, and others. Biopsy needles are specialized medical tools used to extract tissue samples from the breast for examination. The image-guided technologies are magnetic resonance imaging (MRI)-guided breast biopsy, ultrasound-guided breast biopsy, mammography-guided stereotactic biopsy, computed tomography (CT)-guided biopsy, and others, and the procedures are needle breast biopsy, open surgical breast biopsy, and liquid breast biopsy. The applications include hospitals, clinics, diagnostic centers, and others.
What Is The Breast Biopsy Market Size and Share 2026?
The breast biopsy market size has grown strongly in recent years. It will grow from $1.53 billion in 2025 to $1.65 billion in 2026 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to limited availability of advanced biopsy systems, reliance on traditional surgical biopsy methods, increasing breast cancer incidence, growing hospital and diagnostic center infrastructure, adoption of ultrasound-guided procedures.What Is The Breast Biopsy Market Growth Forecast?
The breast biopsy market size is expected to see strong growth in the next few years. It will grow to $2.17 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to technological advancements in liquid biopsy and imaging-guided systems, rising awareness of early breast cancer detection, expansion of diagnostic centers and hospitals, increasing integration of ai and data analytics, development of personalized and precision medicine approaches. Major trends in the forecast period include increasing adoption of minimally invasive biopsy procedures, rising use of liquid biopsy techniques, growth in imaging-guided biopsy systems, expansion of breast cancer diagnostic and screening programs, enhanced focus on patient safety and sample accuracy.Global Breast Biopsy Market Segmentation
1) By Type: Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits, Liquid Biopsy Instruments, Other Types 2) By Image Guided Technology: Magnetic Resonance Imaging (MRI) Guided Breast Biopsy, Ultrasound Guided Breast Biopsy, Mammography Guided Stereotactic Biopsy, Computed Tomography (CT) Guided Biopsy, Other Image Guided Technologies 3) By Procedure: Needle Breast Biopsy, Open Surgical Breast Biopsy, Liquid Breast Biopsy 4) By Application: Hospitals, Clinics, Diagnostic Centers, Other Applications Subsegments: 1) By Biopsy Needles: Core Biopsy Needles, Fine Needle Aspiration (FNA) Needles, Vacuum-Assisted Biopsy Needles, Automatic Biopsy Needles 2) By Guidance Systems: Ultrasound Guidance Systems, MRI Guidance Systems, Stereotactic Guidance Systems, Tomosynthesis Guidance Systems 3) By Biopsy Tables: Adjustable Biopsy Tables, Specialty Biopsy Tables, Imaging-Compatible Biopsy Tables 4) By Localization Wires: Hookwire Localization Devices, Radioguided Localization Wires, Magnetic Seed Localization Systems 5) By Assay Kits: Breast Cancer Assay Kits, Biomarker Detection Kits, Genetic Testing Kits for Breast Cancer 6) By Liquid Biopsy Instruments: Circulating Tumor Cell (CTC) Isolation Devices, Plasma DNA Isolation Kits, Liquid Biopsy Analysis Systems 7) By Other Types: Biopsy Adhesives, Specimen Collection and Transport Devices, Patient Management SystemsWhat Is The Driver Of The Breast Biopsy Market?
The growing prevalence of breast cancer is expected to propel the growth of the breast biopsy market going forward. Breast cancer is a malignant tumor that forms in the cells of the breast tissue and can spread to other parts of the body if not treated promptly. The prevalence of breast cancer is attributed to factors such as increased life expectancy, improved detection methods, and rising awareness about the disease. A breast biopsy is used to obtain tissue samples from suspicious areas in the breast to diagnose and determine the characteristics of breast cancer. For instance, in October 2025, according to the Breastcancer.org, a US-based non-profit organization, reported that in 2025, an estimated 316,950 women are expected to be diagnosed with invasive breast cancer, along with about 59,080 new cases of non-invasive ductal carcinoma in situ (DCIS). Therefore, the growing prevalence of breast cancer is driving the growth of the breast biopsy industry.Key Players In The Global Breast Biopsy Market
Major companies operating in the breast biopsy market are Siemens Healthineers AG, Fujifilm Holdings Corporation, Becton Dickinson and Company BD, Koninklijke Philips, GE HealthCare Technologies Inc, Hologic Inc, Merit Medical Systems, Argon Medical Devices, Canon Medical Systems Corporation, Devicor Medical Products Inc, Planmed Oy, Menarini-Silicon Biosystems, Seno Medical Instruments Inc, Dilon Technologies Inc, INRAD Inc, Promaxo Inc, Cook Medical LLC, Boston Scientific Corporation, Stryker Corporation, Intact Medical Corporation, Scion Medical Technologies LLC, Galini SRL, Ethicon Surgical Technologies, Encapsule Medical Devices LLC, Cardinal Health Inc, Olympus Corporation, F Hoffmann-La Roche Ltd, Biocept Inc.Global Breast Biopsy Market Trends and Insights
Major companies operating in the breast biopsy marker market are focusing on developing innovative products, such as ultrasound-visible site markers, to enhance lesion localization and reduce marker displacement during breast biopsy procedures. An ultrasound-visible site marker is a specially designed implantable device that improves visualization of biopsy sites during imaging and provides stable localization for future surgical intervention. For instance, in August 2023, Mammotome, a US-based provider of breast biopsy and localization technologies, launched HydroMark Plus. This new breast biopsy site marker offers improved lesion visibility on ultrasound, which assists radiologists and surgeons in accurately targeting biopsy sites while reducing the risk of marker displacement during subsequent surgical procedures. As the latest addition to Mammotome’s HydroMark portfolio, HydroMark Plus is designed for enhanced procedural reliability and is slated for nationwide availability in the U.S. by the end of the year. The product’s key features include high ultrasound conspicuity for easy detection, minimized risk of movement within breast tissue, and suitability for a wide variety of breast imaging and interventional workflows. These attributes are aimed at improving clinical outcomes and procedural confidence for both physicians and patients.What Are Latest Mergers And Acquisitions In The Breast Biopsy Market?
In May 2024, Lunit Inc., a South Korea-based medical software company, acquired Volpara Health Technologies Ltd. for an undisclosed amount. With this acquisition, Lunit Inc. will enhance its portfolio with advanced breast imaging and analysis technologies, boosting its capabilities in early cancer detection. Volpara Health Technologies Ltd. is a New Zealand-based provider of breast biopsy.Regional Outlook
North America was the largest region in the breast biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Breast Biopsy Market?
The breast biopsy market consists of revenues earned by providing services such as biopsy procedures, consultations, and diagnostic services. The market value includes the value of related goods sold by the service provider or included within the service offering. The breast biopsy market also includes sales of biodegradable tissue markers, and semi-automated and fully automated biopsy needles. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.Breast Biopsy Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $1.65 billion |
| Revenue Forecast In 2035 | $2.17 billion |
| Growth Rate | CAGR of 7.5% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type, Image Guided Technology, Procedure, Application |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Siemens Healthineers AG, Fujifilm Holdings Corporation, Becton Dickinson and Company BD, Koninklijke Philips, GE HealthCare Technologies Inc, Hologic Inc, Merit Medical Systems, Argon Medical Devices, Canon Medical Systems Corporation, Devicor Medical Products Inc, Planmed Oy, Menarini-Silicon Biosystems, Seno Medical Instruments Inc, Dilon Technologies Inc, INRAD Inc, Promaxo Inc, Cook Medical LLC, Boston Scientific Corporation, Stryker Corporation, Intact Medical Corporation, Scion Medical Technologies LLC, Galini SRL, Ethicon Surgical Technologies, Encapsule Medical Devices LLC, Cardinal Health Inc, Olympus Corporation, F Hoffmann-La Roche Ltd, Biocept Inc. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
Frequently Asked Questions
The Breast Biopsy Market Report 2026 market was valued at $1.53 billion in 2025, increased to $1.65 billion in 2026, and is projected to reach $2.17 billion by 2030.
request a sample hereThe expected CAGR for the Breast Biopsy Market Report 2026 market during the forecast period 2025–2030 is 7.2%.
request a sample hereMajor growth driver of the market includes: Rising Breast Cancer Cases Drive Increasing Demand For Breast Biopsy Procedures in the Breast Biopsy Market Report 2026 market. For further insights on this market,
request a sample hereThe breast biopsy market covered in this report is segmented –
1) By Type: Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits, Liquid Biopsy Instruments, Other Types
2) By Image Guided Technology: Magnetic Resonance Imaging (MRI) Guided Breast Biopsy, Ultrasound Guided Breast Biopsy, Mammography Guided Stereotactic Biopsy, Computed Tomography (CT) Guided Biopsy, Other Image Guided Technologies
3) By Procedure: Needle Breast Biopsy, Open Surgical Breast Biopsy, Liquid Breast Biopsy
4) By Application: Hospitals, Clinics, Diagnostic Centers, Other Applications Subsegments:
1) By Biopsy Needles: Core Biopsy Needles, Fine Needle Aspiration (FNA) Needles, Vacuum-Assisted Biopsy Needles, Automatic Biopsy Needles
2) By Guidance Systems: Ultrasound Guidance Systems, MRI Guidance Systems, Stereotactic Guidance Systems, Tomosynthesis Guidance Systems
3) By Biopsy Tables: Adjustable Biopsy Tables, Specialty Biopsy Tables, Imaging-Compatible Biopsy Tables
4) By Localization Wires: Hookwire Localization Devices, Radioguided Localization Wires, Magnetic Seed Localization Systems
5) By Assay Kits: Breast Cancer Assay Kits, Biomarker Detection Kits, Genetic Testing Kits for Breast Cancer
6) By Liquid Biopsy Instruments: Circulating Tumor Cell (CTC) Isolation Devices, Plasma DNA Isolation Kits, Liquid Biopsy Analysis Systems
7) By Other Types: Biopsy Adhesives, Specimen Collection and Transport Devices, Patient Management Systems
request a sample here1) By Type: Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits, Liquid Biopsy Instruments, Other Types
2) By Image Guided Technology: Magnetic Resonance Imaging (MRI) Guided Breast Biopsy, Ultrasound Guided Breast Biopsy, Mammography Guided Stereotactic Biopsy, Computed Tomography (CT) Guided Biopsy, Other Image Guided Technologies
3) By Procedure: Needle Breast Biopsy, Open Surgical Breast Biopsy, Liquid Breast Biopsy
4) By Application: Hospitals, Clinics, Diagnostic Centers, Other Applications Subsegments:
1) By Biopsy Needles: Core Biopsy Needles, Fine Needle Aspiration (FNA) Needles, Vacuum-Assisted Biopsy Needles, Automatic Biopsy Needles
2) By Guidance Systems: Ultrasound Guidance Systems, MRI Guidance Systems, Stereotactic Guidance Systems, Tomosynthesis Guidance Systems
3) By Biopsy Tables: Adjustable Biopsy Tables, Specialty Biopsy Tables, Imaging-Compatible Biopsy Tables
4) By Localization Wires: Hookwire Localization Devices, Radioguided Localization Wires, Magnetic Seed Localization Systems
5) By Assay Kits: Breast Cancer Assay Kits, Biomarker Detection Kits, Genetic Testing Kits for Breast Cancer
6) By Liquid Biopsy Instruments: Circulating Tumor Cell (CTC) Isolation Devices, Plasma DNA Isolation Kits, Liquid Biopsy Analysis Systems
7) By Other Types: Biopsy Adhesives, Specimen Collection and Transport Devices, Patient Management Systems
Major trend in this market includes: Ultrasound-Visible Markers Enhance Biopsy Site Localization and Detection During Breast Procedures For further insights on this market,
request a sample hereMajor companies operating in the Breast Biopsy Market Report 2026 market are Major companies operating in the breast biopsy market are Siemens Healthineers AG, Fujifilm Holdings Corporation, Becton Dickinson and Company BD, Koninklijke Philips, GE HealthCare Technologies Inc, Hologic Inc, Merit Medical Systems, Argon Medical Devices, Canon Medical Systems Corporation, Devicor Medical Products Inc, Planmed Oy, Menarini-Silicon Biosystems, Seno Medical Instruments Inc, Dilon Technologies Inc, INRAD Inc, Promaxo Inc, Cook Medical LLC, Boston Scientific Corporation, Stryker Corporation, Intact Medical Corporation, Scion Medical Technologies LLC, Galini SRL, Ethicon Surgical Technologies, Encapsule Medical Devices LLC, Cardinal Health Inc, Olympus Corporation, F Hoffmann-La Roche Ltd, Biocept Inc.
request a sample hereNorth America was the largest region in the breast biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breast biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
request a sample here